Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist

Oncology Reports

Volumn 20, Issue 5, 2008, Pages 1289-1294

  Seitz, Stephan ^a,b,f   Hohla, Florian ^a,e,f   Schally, Andrew V ^a,b,f   Moder, Angelika ^e   Engel, Joerg B ^d   Horn, Felicitas ^b   Varga, Josef ^a,f   Zarandi, Marta ^a,f   Ortmann, Olaf ^b   Köster, Frank ^c   Buchholz, Stefan ^a,b,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen receptor; GHRH

Indexed keywords

ESTROGEN RECEPTOR; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR BLOCKING AGENT; JMR 132; SERMORELIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; GHRH(1 29)NH2, PHACTYR(1) ARG(2) P(H)E(4 CL)(6) ALA(8) TYR(ME)(10) HIS(11) ABU(15) HIS(20) NLE(27) ARG(28) HLCR(29); GHRH(1-29)NH2, PHACTYR(1)-ARG(2)-P(H)E(4-CL)(6)-ALA(8)-TYR(ME)(10)-HIS(11)-ABU(15)-HIS(20)-NLE(27)-ARG(28)-HLCR(29)-; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; BREAST TUMOR; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERMORELIN;

EID: 58149346109     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000143     Document Type: Article

References (38)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari JC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005.
2. Anderson WF, Chaterjee N, Ershler WB and Brawley OW: Estrogen receptor breast cancer phenotypes in survelliance, epidemology, and end results database. Breast Cancer Res Treat 76: 27-36, 2002.
3. Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL and Halmos G: Hypothalamic hormones and cancer. Front Neuroendocrinol 22: 248-291, 2001.
4. Schally AV and Varga JL: Antagonistic analogs of growth hormone-releasing hormone: new potential antitumor agents. Trends Endocrinol Metab 10: 383-391, 1999.
5. Varga J and Schally AV: Handbook of Peptides. Kastin A (ed). Elsvier-Academic, New York, pp483-489, 2006.
6. Schally A, Varga JL and Engel JB: Antagonists of growth- hormone-releasing hormone-releasing hormone: an emerging new therapy for cancer. Nat Clin Pract Endocrinol Metab 4: 33-43, 2008.
7. Chatzistamou I, Schally AV, Kiaris H, Politi E, Varga J, Kanellis G, Kalofoutis A, Pafiti A and Koutselini H: Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers. Eur J Endocrinol 151: 391-396, 2004.
8. Halmos G, Schally AV, Czompoly T, Krupa M, Varga JL and Rekasi Z: Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer. J Clin Endocrinol Metab 87: 4707-4714, 2002.
9. Kahan Z, Arencibia JM, Csernus VJ, Groot K, Kineman RD, Robinson WR and Schally AV: Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J Clin Endocrinol Metab 84: 582-589, 1999.
10. Khorrmam O, Garthwaite M, Grosen E and Golos T: Human uterine and ovarian expression of growth hormone releasing hormone messanger mRNA in beign and malignant gynecological conditions. Fertil Steril 75: 174-179, 2001.
11. Garcia-Fernandez MO, Schally AV, Varga JL, Groot K and Busto R: The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation. Breast Cancer Res Treat 77: 15-26, 2003.
12. Kahan Z, Sun B, Schally AV, Arencibia JM, Cai RZ, Groot K and Halmos G: Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II. Cancer 88: 1384-1392, 2000.
13. Pollak M: Endocrine effects of IGF-I on normal and transformed breast cancer epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat 47: 209-217, 1998.
14. Szepeshazi K, Schally AV, Armatis P, Groot K, Hebert F, Feil A, Varga JL and Halmos G: Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth. Endocrinology 142: 4371-4378, 2001.
15. Waters M and Conway-Campbell BL: The oncogenic potential of autocrine human growth hormone in breast cancer. Proc Natl Acad Sci USA 101: 14992-14993, 2004.
16. Kahan Z, Varga JL, Schally AV, Rekasi Z, Armatis P, Chatzistamou L, Czompoly T and Halmos G: Antagonists of growth hormone-releasing hormone arrest the growth of MDA- MB-468 estrogen-independent human breast cancers in nude mice. Breast Cancer Res Treat 60: 71-79, 2000.
17. Rekasi Z, Varga JL, Schally AV, Halmos G, Armatis P, Groot K and Czompoly T: Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers. Endocrinology 141: 2120-2128, 2000.
18. Rekasi Z, Czompoly T, Schally AV and Halmos G: Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc Natl Acad Sci USA 97: 10561-10566, 2000.
19. Havt A, Schally AV, Halmos G, Varga JL, Toller GL, Horvath JE, Szepeshazi K, Koster F, Kovitz K, Groot K, Zarandi M and Kanashiro CA: The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci USA 102: 17424-17429, 2005.
20. Müller EE, Locatelli V and Cocchi D: Neuroendocrine control of growth hormone secretion. Physiol Rev 79: 511-607, 1999.
21. Ramirez JL, Catano JP, Torronteras R, Martinez-Fuentes AJ, Frawley LS, Garcia-Navarro S and Garcia-Navarro F: Growth hormone (GH)-releasing factor differentially activates cyclic adenosine 3′,5′-monophosphate- and inositol phosphate dependent pathways to stimulate GH release in two pocrine somatotrope subpopulations. Endocrinology 140: 1752-1759, 1999.
22. Siriwardana G, Bradford A, Coy D and Zeitler P: Autocrine/paracrine regulation of the breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf and mitogen-activated protein kinase. Mol Endocrinol 20: 2010-2019, 2006.
23. Schally A and Varga JL: Anatgonists of growth hormone-releasing hormone in oncology. Comb Chem High Throughput Screen 9: 163-170, 2006.
24. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 165-159, 1987.
25. Kiaris H, Schally AV, Varga JL, Groot K and Armatis P: Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma. Proc Natl Acad Sci USA 96: 14894-14898, 1999.
26. Busto R, Schally AV, Braczkowski R, Plonowski A, Krupa M, Groot K, Armatis P and Varga JL: Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors. Regul Pept 108: 47-53, 2002.
27. Plonowski A, Schally AV, Busto R, Krupa M, Varga JL and Halmos G: Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers. Peptides 23: 1127-1133, 2002.
28. Csernus V, Schally AV and Groot K: Effect of GHRH and peptides from the vasoactive intestinal peptide family on cAMP production of human cancer cell lines in vitro. J Endocrinol 163: 269-280, 1999.
29. Pombo CM, Zaldive J, Gaylinn BD and Dieguez C: Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 141: 2113-2119, 2000.
30. Jungwirth A, Schally AV, Pinski J, Groot K, Armatis P and Halmos G: Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma. Proc Natl Acad Sci USA 94: 5810-5813, 1997.
31. Pinski J, Schally AV, Groot K, Halmos G, Szepeshazi K, Zarandi M and Armatis P: Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. J Natl Cancer Inst 87: 1787-1794, 1995.
32. Csernus VJ, Schally AV, Kiaris H and Armatis P: Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro. Proc Natl Acad Sci USA 96: 3098-3103, 1999.
33. Kahan Z, Arencibia JM, Csernus VJ, Groot K, Kineman RD, Robinson WR and Schally AV: Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J Clin Endocrinol Metab 84: 582-589, 1999.
34. Chatzistamou I, Schally AV, Varga JL, Groot K, Busto R, Armatis P and Halmos G: Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone. Anticancer Drugs 12: 761-768, 2001.
35. Rekasi Z, Varga JL, Schally AV, Plonowski A, Halmos G, Csernus B, Armatis P and Groot K: Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways. Peptides 22: 879-886, 2001.
36. Barabutis N, Tsellou E, Schally AV, Kouloheri S, Kalofoutis A and Kiaris H: Stimulation of proliferation of MCF-7 breast cancer cells by a transfected slpice variant of growth hormone-releasing hormone receptor. Proc Natl Acad Sci USA 27: 5575-5579, 2007.
37. Kiaris H, Chatzistamou I, Schally A, Halmos G, Varga J, Koutdelimi and Kalofoutis A: Ligand-dependent and independent efects of splice variant 1 of growth hormone-releasing hormone receptor. Proc Natl Acad Sci USA 100: 9512-9517, 1999.
38. Barabutis N and Schally AV: Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines. Br J Cancer (In press).